FGC
MDCO

Financial Gravity Companies’s Medicines Co MDCO Stock Holding History

Financial Gravity Companies’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+17
New +$395 ﹤0.01% 1580
2018
Q1 		$1K Hold
18
– – ﹤0.01% 1341
2017
Q4 		$1K Buy
+18
New +$554 ﹤0.01% 1294

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Financial Gravity Companies's MDCO Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Medicines Co (MDCO) in Q4 2018: 17 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1580 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in MDCO as recently as Q1 2018.

Financial Gravity Companies first reported a position in MDCO in Q4 2017 and has held it in 3 quarters since. The position peaked at $1K in Q1 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Financial Gravity Companies held 17 shares of Medicines Co worth $0 as of Q4 2018.
  • Medicines Co was a new Financial Gravity Companies position in Q4 2018.
  • Medicines Co made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1580 holding.
  • Financial Gravity Companies first reported a position in Medicines Co in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Medicines Co position peaked at $1K in Q1 2018.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.